Publication | Open Access

Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin

Intravenous ImmunoglobulinImmunologyImmune RegulationImmunodominanceNeurochemical BiomarkersImmunotherapyAlzheimer's DiseaseDegenerative PathologyAutoantibodiesAntibody EngineeringNeuroimmunologyMouse ModelAutoimmune DiseaseAutoimmunityHumoral ImmunityImmune FunctionAβ OligomersPharmacologyProtective MechanismsAntibody BiologyNeurodegenerative DiseasesAutoantibody ProductionImmunoglobulin EMedicine